0000899243-22-039023.txt : 20221219
0000899243-22-039023.hdr.sgml : 20221219
20221219172917
ACCESSION NUMBER: 0000899243-22-039023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221215
FILED AS OF DATE: 20221219
DATE AS OF CHANGE: 20221219
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sullivan Eric
CENTRAL INDEX KEY: 0001601797
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38811
FILM NUMBER: 221472174
MAIL ADDRESS:
STREET 1: GOODWIN PROCTER LLP
STREET 2: 53 STATE ST
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC.
CENTRAL INDEX KEY: 0001750019
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 474152751
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-949-5200
MAIL ADDRESS:
STREET 1: 100 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-15
0
0001750019
TCR2 THERAPEUTICS INC.
TCRR
0001601797
Sullivan Eric
100 BINNEY STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial Officer
Stock Option (Right to Buy)
0.97
2022-12-15
4
A
0
40820
0.00
A
2032-12-14
Common Stock
40820
40820
D
Restricted Stock Unit (Right to Buy)
2022-12-15
4
A
0
6804
0.00
A
Common Stock
6804
6804
D
25% of this option shall vest and become exercisable on the one-year anniversary of the date of grant, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
The restricted stock units will vest 25% on the one-year anniversary of the date of grant, with the remainder vesting in three equal annual installments thereafter.
/s/ Margaret Siegel as Attorney-in-Fact
2022-12-19